Stiripentol/valproate

Stiripentol/valproate Reactions 1704, p348 - 2 Jun 2018 Worsening of absence seizures, myoclonus and recurrent pancreatitis: 2 case reports In a prospective, open-label observational study of 41 patients, one patient developed myoclonus and worsening of absence seizures on stiripentol and one patient developed recurrent pancreatitis on treatment with valproate and stiripentol [ages, sexes, routes and dosages not stated, not all durations of treatments to reactions onsets stated]. Patient 1: The patient had Dravet syndrome and received treatment with stiripentol. Additionally, the patient was receiving other unspecified antiepileptic medication. The stiripentol dose was gradually increased; however, at increased doses the patient developed myoclonus along with transient worsening of absence seizures. The patient continued taking stiripentol due to it’s beneficial effects on the tonic-clonic seizures. Patient 2: The patient had Dravet syndrome and had been receiving valproate since the age of 8 months. At the age of three years, the patient started receiving stiripentol. Two months after starting stiripentol, the patient developed an episode of pancreatitis. Over the next two years, the patient developed 10 such episodes. The episodes involved abdominal pain and vomiting, with serum lipase rising upto 7000 units per litre and returning to normal between attacks. The patient’s valproate http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Stiripentol/valproate

Reactions Weekly, Volume 1704 (1) – Jun 2, 2018

Stiripentol/valproate

Abstract

Reactions 1704, p348 - 2 Jun 2018 Worsening of absence seizures, myoclonus and recurrent pancreatitis: 2 case reports In a prospective, open-label observational study of 41 patients, one patient developed myoclonus and worsening of absence seizures on stiripentol and one patient developed recurrent pancreatitis on treatment with valproate and stiripentol [ages, sexes, routes and dosages not stated, not all durations of treatments to reactions onsets stated]. Patient 1: The patient had Dravet...
Loading next page...
 
/lp/springer_journal/stiripentol-valproate-rJNRnkbn3z
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-018-46991-x
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p348 - 2 Jun 2018 Worsening of absence seizures, myoclonus and recurrent pancreatitis: 2 case reports In a prospective, open-label observational study of 41 patients, one patient developed myoclonus and worsening of absence seizures on stiripentol and one patient developed recurrent pancreatitis on treatment with valproate and stiripentol [ages, sexes, routes and dosages not stated, not all durations of treatments to reactions onsets stated]. Patient 1: The patient had Dravet syndrome and received treatment with stiripentol. Additionally, the patient was receiving other unspecified antiepileptic medication. The stiripentol dose was gradually increased; however, at increased doses the patient developed myoclonus along with transient worsening of absence seizures. The patient continued taking stiripentol due to it’s beneficial effects on the tonic-clonic seizures. Patient 2: The patient had Dravet syndrome and had been receiving valproate since the age of 8 months. At the age of three years, the patient started receiving stiripentol. Two months after starting stiripentol, the patient developed an episode of pancreatitis. Over the next two years, the patient developed 10 such episodes. The episodes involved abdominal pain and vomiting, with serum lipase rising upto 7000 units per litre and returning to normal between attacks. The patient’s valproate

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month